We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Shire Faces Another Challenge To Patent For Adderall XR

Law360 (December 3, 2004, 12:00 AM EST) -- Another generic drug maker has launched a challenge against the patent for Shire Pharmaceuticals Group PLC’s Adderall XR, a blockbuster drug for the treatment of attention deficit and hyperactivity disorders....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.